companydata.dkGalecteye Pharma ApS: Financial statements 2019
CVR: 38248243
Galecteye Pharma ApS (CVR 38248243) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -5,000 and a net result of DKK -6,020 compared with DKK -11,050 the year before. Equity amounted to DKK 14,777. The solvency ratio was 11.9%.
- Gross Profit
- -5,000 kr.
- Profit/Loss
- -6,020 kr.
- Equity
- 14,777 kr.
- Total Assets
- 124,099 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -5 t. | -6 t. | 15 t. | - |
| 2018 | - | -10 t. | -11 t. | 21 t. | - |
| 2017 | - | -17 t. | -18 t. | 32 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
Galecteye Pharma ApS has published its annual report for 2018. Gross profit came to DKK -10,040, and the net result was DKK -11,050.
About Galecteye Pharma ApS
Galecteye Pharma ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2016 and dissolved in 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -6,250 and a net result of DKK -7,280 compared with DKK -6,020 the year before. Equity amounted to DKK 7,497.